Bioavailability and bioequivalence studies
Our In-House expert with in-depth experience in understanding molecule behavior and technical expertise facilitates the clinical centres (CRO) to establish robust bioequivalence study protocols and study designs. Our internal expert auditing team identifies and qualifies the EU approved clinical and bioanalytical centres.
Riviera's strategic partnership with efficient clinical CROs offers clients an integrated and cost-effective solution. Each study is thoroughly designed and coordinated with the clinical centres ensuring high success rates in BA/BE.
